Analysis indicates lower incidence of 13 types of obesity-related tumors in GLP-1 drug users, such as tirzepatide and semaglutide
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.